AR038306A1 - Composicion farmaceutica dispersable oralmente de 2-({2-metoxi-2-[(3-trifluorometil)fenil]etil}amino)etil-4-(2-{[2-(9h-fluoren-9-il)acetil]amino}etil)benzoato - Google Patents
Composicion farmaceutica dispersable oralmente de 2-({2-metoxi-2-[(3-trifluorometil)fenil]etil}amino)etil-4-(2-{[2-(9h-fluoren-9-il)acetil]amino}etil)benzoatoInfo
- Publication number
- AR038306A1 AR038306A1 ARP030100196A ARP030100196A AR038306A1 AR 038306 A1 AR038306 A1 AR 038306A1 AR P030100196 A ARP030100196 A AR P030100196A AR P030100196 A ARP030100196 A AR P030100196A AR 038306 A1 AR038306 A1 AR 038306A1
- Authority
- AR
- Argentina
- Prior art keywords
- etil
- amino
- fluoren
- benzoate
- phenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composición farmacéutica sólida dispersable oralmente de 2-({2-metoxi-2-(3-trifluorometil)fenil]etil}amino)etil-4-(2-{[2-(9H-fluoren-9-il)acetil]amino}etil)benzoato (compuesto A) que contiene el compuesto A o una de sus sales farmacéuticamente aceptables, y gránulos que consisten en lactosa y almidón cosecados.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0200793A FR2834891B1 (fr) | 2002-01-23 | 2002-01-23 | Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate |
Publications (1)
Publication Number | Publication Date |
---|---|
AR038306A1 true AR038306A1 (es) | 2005-01-12 |
Family
ID=27589557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030100196A AR038306A1 (es) | 2002-01-23 | 2003-01-23 | Composicion farmaceutica dispersable oralmente de 2-({2-metoxi-2-[(3-trifluorometil)fenil]etil}amino)etil-4-(2-{[2-(9h-fluoren-9-il)acetil]amino}etil)benzoato |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR038306A1 (es) |
FR (1) | FR2834891B1 (es) |
WO (1) | WO2003061647A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2966828B1 (fr) | 2010-11-02 | 2012-12-28 | Roquette Freres | Poudre de polysaccharide et de polyol, comprimable et de haute viscosite |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3506276C1 (de) * | 1985-02-22 | 1986-04-24 | Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring | Direkttablettiermittel |
FR2677647B1 (fr) * | 1991-06-14 | 1993-08-20 | Adir | Nouveaux derives de benzoate d'ethanolamine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
EP0745382B1 (en) * | 1994-01-31 | 2003-11-12 | Yamanouchi Pharmaceutical Co. Ltd. | Intraorally soluble compressed molding and process for producing the same |
DE60036205T2 (de) * | 2000-07-27 | 2008-05-21 | Roquette Frères | Granulat bestehend aus Stärke und Laktose |
-
2002
- 2002-01-23 FR FR0200793A patent/FR2834891B1/fr not_active Expired - Fee Related
-
2003
- 2003-01-22 WO PCT/FR2003/000199 patent/WO2003061647A1/fr not_active Application Discontinuation
- 2003-01-23 AR ARP030100196A patent/AR038306A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
FR2834891B1 (fr) | 2004-02-27 |
FR2834891A1 (fr) | 2003-07-25 |
WO2003061647A1 (fr) | 2003-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
LU92496I2 (fr) | Combinaison de dapagliflozine ou d'un sel pharmaceutiquement acceptable de celle-ci et de merformineou d'un sel pharmaceutiquement acceptable de cell-ci, telle que protégée par le brevet de base EP1506211 B1 | |
IL165383A (en) | Pharmaceutical compositions comprising a salt or co-crystal of celecoxib, surfactant and a cellulose derivative | |
ECSP055568A (es) | Composición de comprimido de liberación sostenida de pramipexol | |
GEP20074047B (en) | Pramipexole once-daily dosage form | |
RS52625B (en) | FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES | |
RS50140B (sr) | Postupak za dobijanje perkihinina i njegova upotreba | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
ATE485049T1 (de) | Physiologisch aktive zusammensetzung gegen diabetes | |
MXPA05007609A (es) | Antagonista de un receptor sensible al calcio. | |
IS8461A (is) | 2-(3,4-dímetýlfenýl)-4-{[2-hýdroxý-3'(1H-tetrasól-5-ýl)bífenýl-3-ýl]-hýdrasónó}-5-metýl-2,4-díhýdrópýrasól-3-ónkólín | |
SE0101932D0 (sv) | Pharmaceutical combinations | |
MXPA05011176A (es) | Derivados de carboxamida como agentes antidiabeticos. | |
BRPI0415053A (pt) | inibidor de p-glicoproteìna, método para preparar o mesmo e composição farmacêutica que compreende o mesmo | |
NO20045385L (no) | Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff | |
EP1602645A4 (en) | NITROGENIC HETEROCYCLIC DERIVATIVE WITH 2,6-DISUBSTITUTED STYRYL REST | |
BR0314129A (pt) | Formulações de liberação modificadas de oxcarbazepina e derivados destas | |
AR038305A1 (es) | Composicion farmaceutica dispersable oralmente de perindopril | |
AR038206A1 (es) | Composicion farmaceutica dispersable oralmente de ivabradina | |
HRP20080521T3 (en) | Orodispersible pharmaceutical composition of an antithrombotic compound | |
MXPA05006889A (es) | Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. | |
GB0212410D0 (en) | Organic compounds | |
AR038306A1 (es) | Composicion farmaceutica dispersable oralmente de 2-({2-metoxi-2-[(3-trifluorometil)fenil]etil}amino)etil-4-(2-{[2-(9h-fluoren-9-il)acetil]amino}etil)benzoato | |
SE0200198D0 (sv) | New use | |
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |